Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment

Journal of Artificial Organs

Volumn 18, Issue 1, 2015, Pages 20-26

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Nitta, Daisuke ^a   Fujino, Takeo ^a   Inaba, Toshiro ^a   Maki, Hisataka ^a   Hatano, Masaru ^a   Kinoshita, Osamu ^a   Nawata, Kan ^a   Kyo, Shunei ^a   Ono, Minoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autonomic nerve; Heart failure; Heart rate variability; Reverse remodeling

Indexed keywords

ADRENALIN; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; NORADRENALIN;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CORRELATIONAL STUDY; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INDEX; HEART RATE VARIABILITY; HUMAN; JAPAN; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN BLOOD LEVEL; PULMONARY ARTERY OCCLUSION PRESSURE; ROTATION; SYMPATHETIC TONE; TREATMENT OUTCOME; ADRENERGIC SYSTEM; HEART ASSIST DEVICE; HEART RATE; HEART VENTRICLE; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; FEMALE; HEART FAILURE; HEART RATE; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROTATION; SYMPATHETIC NERVOUS SYSTEM; YOUNG ADULT;

EID: 84925506169     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-014-0800-2     Document Type: Article

References (20)

1. Floras JS. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand. 2003;177:391–8.
2. Metra M, Nodari S, D’Aloia A, Bontempi L, Boldi E, Cas LD. A rationale for the use of beta-blockers as standard treatment for heart failure. Am Heart J. 2000;139:511–21.
3. The Cardiac Insufficiency Bisoprolol Study II. (CIBIS-II): a randomised trial. Lancet. 1999;353:9–13.
4. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–55.
5. George RS, Birks EJ, Cheetham A, Webb C, Smolenski RT, Khaghani A, Yacoub MH, Kelion A. The effect of long-term left ventricular assist device support on myocardial sympathetic activity in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2013;15:1035–43.
6. Slaughter MS, Pagani FD, Rogers JG, Miller LW, Sun B, Russell SD, Starling RC, Chen L, Boyle AJ, Chillcott S, Adamson RM, Blood MS, Camacho MT, Idrissi KA, Petty M, Sobieski M, Wright S, Myers TJ, Farrar DJ. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39.
7. Hori M, Nagai R, Izumi T, Matsuzaki M. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study. Heart Vessel. 2014;29:238–47.
8. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation. 1999;100:1056–64.
9. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17:354–81.
10. Sawada Y, Ohtomo N, Tanaka Y, Tanaka G, Yamakoshi K, Terachi S, Shimamoto K, Nakagawa M, Satoh S, Kuroda S, Iimura O. New technique for time series analysis combining the maximum entropy method and non-linear least squares method: its value in heart rate variability analysis. Med Biol Eng Comput. 1997;35:318–22.
11. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178–93.
12. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213:220–2.
13. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–23.
14. Skorecki KL, Brenner BM. Body fluid homeostasis in man. A contemporary overview. Am J Med. 1981;70:77–88.
15. Frye RL, Braunwald E. Studies on Starling’s law of the heart. I. The circulatory response to acute hypervolemia and its modification by ganglionic blockade. J Clin Invest. 1960;39:1043–50.
16. Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, Kinoshita O, Nawata K, Kyo S, Ono M, Komuro I. Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Circ J. 2014;78:2259–67.
17. Bristow MR. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol. 1997;80:26L–40L.
18. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 1996;94:2285–96.
19. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med. 1976;294:1165–70.
20. Imamura T, Kinugawa K, Kato N, Muraoka H, Fujino T, Inaba T, Maki H, Kinoshita O, Hatano M, Kyo S, Ono M. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J. 2014;78:625–33.